ERIC protocol
OtherERIC protocol is an aerobic exercise protocol with 5 levels of intensity
NCT Number: NCT04733365
An aerobic physical exercise protocol will be applied to patients admitted in ward due to decompensated heart failure, in order to validate the efficacy and safety of physical exercise in this phase of clinical stabilization, through the said training protocol - ERIC program.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hospital Infante D Pedro, Aveiro, Portugal
With the objective of validating the efficacy and safety of physical exercise as a therapeutic resource in patients admitted for decompensated heart failure; will be applied, by rehabilitation nurses, a protocol of physical exercise, with increasing levels of intensity. Patients who meet the inclusion criteria will be randomized through an online program (randomizer.org) and the ERIC protocol will be applied to the test group. The control group will be implemented the usual care of rehabilitation nursing. The ERIC protocol comprises 5 levels of intensity, as following shown:
Stage 1 - respiratory and calisthenic exercises (5-10 minutes) Stage 2 - pedaler for 5-10 minutes Stage 3 - aerobic training: walking on the corridor for 5-10 minutes Stage 4 - aerobic training: walking on the corridor for 10-15 minutes Stage 5 - aerobic training: walking on the corridor for 15 minutes + climbing stairs for 5 minutes
All patients will be monitored and followed up by a rehabilitation nurse while they are doing the exercise. The investigator decides, depending on the patient's performance and clinical conditions, the form of progression in the program, but it is mandatory to follow the previously defined levels of intensity. Patients in the test group may start the program only on stage I or II according to clinical criteria.
At admission of the patients (test group and control group) clinical and sociodemographic parameters are evaluated, as well as data related to Barthel's indices and London Chest of activities of daily living (LCADL). At the discharge date, the Barthel index and the LCADL scale will also be evaluated, as well as the 6-minute walking test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ERIC protocol is an aerobic exercise protocol with 5 levels of intensity
Time frame: Through study completion, an average of 1 year
Number of meters walked in the 6 minute walking test
Time frame: Through study completion, an average of 1 yeare
Barthel evaluates dependence on self-care, it ranges from 0 to 100. The higher score inidcates more independence on the performance of self-care activities
Time frame: Through study completion, an average of 1 year
LCADL acesses how dyspnea affects self-care. It ranges from 9 to 45, the lower scores represents less dyspnea during the activities, representing a better status.
Time frame: Through study completion, an average of 1 year
Number of adverse events occured during in the training group
Centro Hospitalar do Porto
Other
Nursing Rehabilitation on Patients Admitted by Recently Decompensated Heart Failure (ERIC Program) - Impact of Exercise
Acronym: ERIC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03838003
Behavior, Cardiovascular Diseases
Porto, Portugal
View Trial DetailsNCT06965712
Cardiovascular Diseases, Decompensated Heart Failure
Miami, Florida, United States
View Trial DetailsNCT02997462
Cardiovascular Diseases, Decompensated Heart Failure
Ann Arbor, Michigan, United States
View Trial DetailsNCT04493346
Cardiovascular Diseases, Cirrhosis, Liver
Dallas, Texas, United States
View Trial Details